Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting

While the introduction of combination highly active antiretroviral therapy (HAART) regimens represents an important advance in the management of human immunodeficiency virus (HIV)-infected patients, tolerability can be an issue and the use of several different agents may produce problems. The switch...

Descripción completa

Detalles Bibliográficos
Autores principales: Arribas, José R, Doroana, Manuela, Turner, Dan, Vandekerckhove, Linos, Streinu-Cercel, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610245/
https://www.ncbi.nlm.nih.gov/pubmed/23347595
http://dx.doi.org/10.1186/1742-6405-10-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610245/
https://www.ncbi.nlm.nih.gov/pubmed/23347595
http://dx.doi.org/10.1186/1742-6405-10-3

Ejemplares similares